BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20153576)

  • 1. Inhibition of the transcriptional function of p53 by EWS-Fli1 chimeric protein in Ewing Family Tumors.
    Li Y; Tanaka K; Fan X; Nakatani F; Li X; Nakamura T; Takasaki M; Yamamoto S; Iwamoto Y
    Cancer Lett; 2010 Aug; 294(1):57-65. PubMed ID: 20153576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
    Hahm KB; Cho K; Lee C; Im YH; Chang J; Choi SG; Sorensen PH; Thiele CJ; Kim SJ
    Nat Genet; 1999 Oct; 23(2):222-7. PubMed ID: 10508522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G(1)regulatory genes.
    Matsumoto Y; Tanaka K; Nakatani F; Matsunobu T; Matsuda S; Iwamoto Y
    Br J Cancer; 2001 Mar; 84(6):768-75. PubMed ID: 11259090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.
    Lin PP; Brody RI; Hamelin AC; Bradner JE; Healey JH; Ladanyi M
    Cancer Res; 1999 Apr; 59(7):1428-32. PubMed ID: 10197607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
    Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
    Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.
    Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T
    Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of the genomic breakpoint junction in a t(11;22) translocation in Ewing sarcoma.
    Obata K; Hiraga H; Nojima T; Yoshida MC; Abe S
    Genes Chromosomes Cancer; 1999 May; 25(1):6-15. PubMed ID: 10221334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.
    Tanaka K; Iwakuma T; Harimaya K; Sato H; Iwamoto Y
    J Clin Invest; 1997 Jan; 99(2):239-47. PubMed ID: 9005992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene.
    Thompson AD; Braun BS; Arvand A; Stewart SD; May WA; Chen E; Korenberg J; Denny C
    Oncogene; 1996 Dec; 13(12):2649-58. PubMed ID: 9000139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids.
    Athanasiou M; LeGallic L; Watson DK; Blair DG; Mavrothalassitis G
    Cancer Gene Ther; 2000 Aug; 7(8):1188-95. PubMed ID: 10975680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The possible role of EWS-Fli1 in evasion of senescence in Ewing family tumors.
    Matsunobu T; Tanaka K; Nakamura T; Nakatani F; Sakimura R; Hanada M; Li X; Okada T; Oda Y; Tsuneyoshi M; Iwamoto Y
    Cancer Res; 2006 Jan; 66(2):803-11. PubMed ID: 16424012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors.
    Hu-Lieskovan S; Zhang J; Wu L; Shimada H; Schofield DE; Triche TJ
    Cancer Res; 2005 Jun; 65(11):4633-44. PubMed ID: 15930281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An association between viral genes and human oncogenic alterations: the adenovirus E1A induces the Ewing tumor fusion transcript EWS-FLI1.
    Sanchez-Prieto R; de Alava E; Palomino T; Guinea J; Fernandez V; Cebrian S; LLeonart M; Cabello P; Martin P; San Roman C; Bornstein R; Pardo J; Martinez A; Diaz-Espada F; Barrios Y; Ramon y Cajal S
    Nat Med; 1999 Sep; 5(9):1076-9. PubMed ID: 10470089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric EWS-FLI1 transcript in a Ewing cell line with a complex t(11;22;14) translocation.
    Bonin G; Scamps C; Turc-Carel C; Lipinski M
    Cancer Res; 1993 Aug; 53(16):3655-7. PubMed ID: 8339272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II.
    Petermann R; Mossier BM; Aryee DN; Khazak V; Golemis EA; Kovar H
    Oncogene; 1998 Aug; 17(5):603-10. PubMed ID: 9704926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells.
    Riggi N; Cironi L; Provero P; Suvà ML; Kaloulis K; Garcia-Echeverria C; Hoffmann F; Trumpp A; Stamenkovic I
    Cancer Res; 2005 Dec; 65(24):11459-68. PubMed ID: 16357154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
    García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
    Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein.
    Spahn L; Siligan C; Bachmaier R; Schmid JA; Aryee DN; Kovar H
    Oncogene; 2003 Oct; 22(44):6819-29. PubMed ID: 14534527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of protein-protein interactions in the antiapoptotic function of EWS-Fli-1.
    Ramakrishnan R; Fujimura Y; Zou JP; Liu F; Lee L; Rao VN; Reddy ES
    Oncogene; 2004 Sep; 23(42):7087-94. PubMed ID: 15273724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells.
    Thompson AD; Teitell MA; Arvand A; Denny CT
    Oncogene; 1999 Sep; 18(40):5506-13. PubMed ID: 10523827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.